NCT06401824 2025-05-06Sacituzumab Govitecan and Bevacizumab for NSCLC Brain MetastasesMaastricht University Medical CenterPhase 2 Recruiting25 enrolled
NCT06667167 2025-01-17First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+TrodelvyShaare Zedek Medical CenterPhase 2 Recruiting21 enrolled